Notes from the field: Multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy - United States, March-April 2012

Morbidity and Mortality Weekly Report

Volumn 61, Issue 17, 2012, Pages 310-311

  Huang, Suber ^a   Dugel, Pravin ^a   Williams, George ^b   Oyong, Kelsey ^c   Tyson, Clara ^c   Mascola, Laurene ^c   Trivedi, Kavita K ^d   Duran, Julie ^e   Millay, Shannon ^f   Black, Stephanie ^g   Conway, Judith ^h   Straif Bourgeois, Susanne ⁱ   Sowadsky, Rick ^j   Lee, Ellen H ^k   Török, Tom ^l   Sun, Benjamin ^l   Lockhart, Shawn ^m   Harris, Julie ^m   Park, Benjamin J ^m   Smith, Rachel ⁿ   Mikosz, Christina ⁿ   Dantes, Raymund ⁿ   Grant, Yoran ⁿ   more..

^a Assoc Res in Vis and Ophthalmol   (United States)

^b American Academy of Ophthalmology   (United States)

^c Los Angeles County Department of Public Health   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e Colorado Dept of Public Health and Environment ^*  (United States)

^f INDIANA STATE DEPARTMENT OF HEALTH   (United States)

^g CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

^h ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ Louisiana Office of Public Health   (United States)

^j Nevada State Health Division   (United States)

^k NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^l Office of Public Health Preparedness and Response   (United States)

^m NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

ⁿ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COOMASSIE BRILLIANT BLUE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FUCHSINE;

ASCOMYCETES; CHEMISTRY; DRUG CONTAMINATION; DRUG FORMULATION; DRUG LABELING; ENDOPHTHALMITIS; EPIDEMIC; EYE SURGERY; FUSARIOSIS; FUSARIUM; HUMAN; ISOLATION AND PURIFICATION; NOTE; PHARMACY; UNITED STATES; VITRECTOMY;

ASCOMYCOTA; DISEASE OUTBREAKS; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG LABELING; ENDOPHTHALMITIS; FUSARIOSIS; FUSARIUM; HUMANS; INDICATORS AND REAGENTS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PHARMACIES; ROSANILINE DYES; UNITED STATES; VITRECTOMY;

EID: 84862000908     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 2011;31:1525-33.
2. Eifrig CWG, Scott IU, Flynn HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 2004;138:799-802.
3. Kastango ES, Bradshaw BD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health Syst Pharm 2004;6:1928-38.
4. Food and Drug Administration. The special risks of pharmacy compounding. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2007. Available at http://www.fda.gov/forconsumers/consumerupdates/ucm107836.htm. Accessed April 30, 2012.
5. Goldberg RA, Flynn HW, Isom RF, Miller D, Gonzalez S. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 2012;153:204-8. e1.